EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Opposing Metabolic Effects of Growth Hormone and IGF-I: Review and Clinical Implications

Zvi Laron iD, Haim Werner

Endocrine Reviews · 2025

DOI: 10.1210/endrev/bnaf022 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrine Reviews, 2025. Verfasst von Zvi Laron und 1 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology and Diabetes Research Unit, Schneider Children's Medical Center, Petah Tikva 4920235, Israel. Hauptthemen laut MEDLINE: Insulin-Like Growth Factor I, Growth Hormone, Human Growth Hormone. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 184 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The growth hormone (GH)/insulin-like growth factor I (IGF-I) endocrine system has a central role in metabolism and growth. The Somatomedin Hypothesis, postulated in the mid-1950s, claimed that the biological activities of pituitary GH are mediated by a liver-produced peptide termed somatomedin or IGF-I. In spite of the fact that this theory has been modified several times throughout the years to accommodate new developments in the field, it is still regarded as the main conceptual framework in the area of GH and IGF-I biology. Regardless of the unifying view that emanates from the Somatomedin Hypothesis, several opposing activities of GH and IGF-I have been described over the years. The present review addresses some of these metabolic activities, including diverging effects of these hormones on serum lipoprotein(a), sex hormone–binding globulin, insulin secretion, and adiponectin/leptin biology. In addition, we propose a number of potential mechanisms that can probably provide a cellular and biochemical basis for these divergent actions. Understanding the complex interactions between the GH and IGF-I signaling pathways might improve our understanding of basic molecular endocrine processes and result in potential clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin-Like Growth Factor IGrowth HormoneHuman Growth HormoneHumansAnimalsSignal TransductionAdiponectinLeptinSex Hormone-Binding GlobulinInsulin

Stichwörter der Autor:innen

adiponectingrowth hormone (GH)insulininsulin-like growth factor I (IGF-I)leptinlipoprotein (a) [Lp(a)]sex hormone–binding globulin (SHBG)

Substanzen

Insulin-Like Growth Factor IGrowth HormoneHuman Growth HormoneAdiponectinLeptinSex Hormone-Binding GlobulinInsulin

Autor:innen und Institutionen

  • Endocrinology and Diabetes Research Unit, Schneider Children's Medical Center, Petah Tikva 4920235, Israel.
  • Department of Pediatrics, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv 6139001, Israel.
  • Department of Human Molecular Genetics and Biochemistry, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv 6139001, Israel.

ORCID-Profile: Zvi Laron

Zitieren

APA

Laron, Z., & Werner, H. (2025). Opposing Metabolic Effects of Growth Hormone and IGF-I: Review and Clinical Implications. Endocrine Reviews. https://doi.org/10.1210/endrev/bnaf022

Vancouver

Laron Z, Werner H. Opposing Metabolic Effects of Growth Hormone and IGF-I: Review and Clinical Implications. Endocrine Reviews. 2025. doi:10.1210/endrev/bnaf022

BibTeX
@article{Laron2025,
  author = {Laron, Zvi and Werner, Haim},
  title = {Opposing Metabolic Effects of Growth Hormone and IGF-I: Review and Clinical Implications},
  journal = {Endocrine Reviews},
  year = {2025},
  doi = {10.1210/endrev/bnaf022}
}
Kostenlos starten →